[July 28, 2016] |
|
Viral RNA Polymerase Inhibitors Pipeline Insights Report 2016 - Research and Markets
Research and Markets has announced the addition of the "Viral
RNA Polymerase Inhibitors -Pipeline Insights, 2016" report to
their offering.
Viral RNA Polymerase Inhibitors-Pipeline Insights, 2016 provides in
depth insights on the pipeline drugs and their development activities
around the Viral RNA Polymerase Inhibitors. The report covers the
product profiles in various stages of development including Discovery,
Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
The report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for Viral RNA
Polymerase Inhibitors.
The report also assesses the Viral RNA Polymerase Inhibitors
therapeutics by Monotherapy, Combination products, molecule type and
Route of Administration.
Scope
-
The report provides competitive pipeline landscape of Viral RNA
Polymerase Inhibitors
-
The report provides pipeline products under rug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
-
Coverage of the Viral RNA Polymerase Inhibitors pipeline on the basis
of target, MOA, route of administration, technology involved and
molecule type
-
The report reviews key players involved in the therapeutics
development for Viral RNA Polymerase Inhibitors and also provide
company profiling
-
The report also gives the information of dormant and discontinued
pipeline projects
-
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Viral RNA Polymerase Inhibitors Overview
-
Viral RNA Polymerase Inhibitors Pipeline Therapeutics
-
Viral RNA Polymerase Inhibitors Therapeutics under Development by
Companies
-
Viral RNA Polymerase Inhibitors Filed and Phase III Products
-
Comparative Analysis
-
Viral RNA Polymerase Inhibitors Phase II Products
-
Comparative Analysis
-
Viral RNA Polymerase Inhibitors Phase I and IND Filed Products
-
Comparative Analysis
-
Viral RNA Polymerase Inhibitors Discovery and Pre-Clinical Stage
Products
-
Comparative Analysis
-
Drug Candidate Profiles
-
Viral RNA Polymerase Inhibitors - Therapeutics Assessment
-
Assessment by Monotherapy Products
-
Assessment by Combination Products
-
Assessment by Route of Administration
-
Assessment by Molecule Type
-
Viral RNA Polymerase Inhibitors - Discontinued Products
-
Viral RNA Polymerase Inhibitors - Dormant Products
-
Companies Involved in Therapeutics Development for Viral RNA
Polymerase Inhibitors
For more information visit http://www.researchandmarkets.com/research/6f9lsh/viral_rna
View source version on businesswire.com: http://www.businesswire.com/news/home/20160728005643/en/
[ Back To TMCnet.com's Homepage ]
|